Multiple Myeloma News and Research

RSS
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Subcutaneous injection of teclistamab drug shows promise in treating aggressive multiple myeloma

Subcutaneous injection of teclistamab drug shows promise in treating aggressive multiple myeloma

MIT engineers develop a method to turn off specific genes in bone marrow cells

MIT engineers develop a method to turn off specific genes in bone marrow cells

Researchers find new way to create natural compound that shows promise as anti-cancer agent

Researchers find new way to create natural compound that shows promise as anti-cancer agent

A safer treatment harnesses the body's cancer-fighting T cells to fight multiple myeloma

A safer treatment harnesses the body's cancer-fighting T cells to fight multiple myeloma

Genome sequencing reveals signposts in DNA for cancer, disease risk

Genome sequencing reveals signposts in DNA for cancer, disease risk

Immune System Changes Occur Early In Development Of Multiple Myeloma

Immune System Changes Occur Early In Development Of Multiple Myeloma

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.